150 related articles for article (PubMed ID: 10990084)
1. A specific structural alteration in the heparan sulphate of human glomerular basement membrane in diabetes.
Edge AS; Spiro RG
Diabetologia; 2000 Aug; 43(8):1056-9. PubMed ID: 10990084
[TBL] [Abstract][Full Text] [Related]
2. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
van den Born J; Berden JH
Nephrol Dial Transplant; 1995; 10(8):1277-9. PubMed ID: 8538909
[No Abstract] [Full Text] [Related]
3. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
Templeton DM
Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
[TBL] [Abstract][Full Text] [Related]
5. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
6. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials.
Nakanishi H; Oguri K; Yoshida K; Itano N; Takenaga K; Kazama T; Yoshida A; Okayama M
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):215-24. PubMed ID: 1445266
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
Nerlich A; Schleicher E
Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
[TBL] [Abstract][Full Text] [Related]
8. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
Rada JA; Carlson EC
Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
[TBL] [Abstract][Full Text] [Related]
9. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
[TBL] [Abstract][Full Text] [Related]
10. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
11. Decreased glomerular basement membrane heparan sulfate proteoglycan in essential hypertension.
Heintz B; Stöcker G; Mrowka C; Rentz U; Melzer H; Stickeler E; Sieberth HG; Greiling H; Haubeck HD
Hypertension; 1995 Mar; 25(3):399-407. PubMed ID: 7875766
[TBL] [Abstract][Full Text] [Related]
12. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulphate proteoglycans from human glomerular and tubular basement membranes are related molecules.
van den Heuvel LP; Veerkamp JH; van den Born J; Monnens LA; Berden JH
Biochem Soc Trans; 1990 Oct; 18(5):960. PubMed ID: 2083767
[No Abstract] [Full Text] [Related]
14. Ultrastructural immunogold studies of heparan sulphate proteoglycan in normal human glomeruli and glomerulonephritis.
Moss J; Woodrow DF; Shore I; Gower P; Phillips M; Spiro RG
J Pathol; 1990 Jun; 161(2):137-43. PubMed ID: 2143222
[TBL] [Abstract][Full Text] [Related]
15. Association between heparan sulfate proteoglycan excretion and proteinuria after renal transplantation.
Stefanidis I; Heintz B; Stöcker G; Mrowka C; Sieberth HG; Haubeck HD
J Am Soc Nephrol; 1996 Dec; 7(12):2670-6. PubMed ID: 8989747
[TBL] [Abstract][Full Text] [Related]
16. Comparison of heparan sulphate proteoglycans from bovine glomerular basement membranes with those from whole cortex.
Dossett RF; Anderson JC
Biochem Soc Trans; 1990 Oct; 18(5):959. PubMed ID: 2083766
[No Abstract] [Full Text] [Related]
17. Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus.
Young ID; Ailles L; Narindrasorasak S; Tan R; Kisilevsky R
Arch Pathol Lab Med; 1992 Sep; 116(9):951-4. PubMed ID: 1524461
[TBL] [Abstract][Full Text] [Related]
18. The glomerular basement membrane charge-selectivity barrier: an oversimplified concept?
Goode NP; Shires M; Davison AM
Nephrol Dial Transplant; 1996 Sep; 11(9):1714-6. PubMed ID: 8918607
[No Abstract] [Full Text] [Related]
19. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin.
Moss J; Shore I; Woodrow D
Histopathology; 1994 May; 24(5):427-35. PubMed ID: 8088714
[TBL] [Abstract][Full Text] [Related]
20. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane.
Parthasarathy N; Spiro RG
Diabetes; 1982 Aug; 31(8 Pt 1):738-41. PubMed ID: 6219021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
